Frost & Sullivan: Patients Revive Healthcare Investments as Demand for High-quality Care Grows

Description

Frost & Sullivan: Patients ReviveFrost & Sullivan: Patients Revive Healthcare Investments as Demand for High-quality Care Grows PR Newswire MOUNTAIN VIEW, California, April 8, 2014 -- PEVC deal activity intensifies in the US and Europe while transformations in business models and delivery advance Though private equity and venture capital (PEVC) investments in the global healthcare industry have been on the decline since 2011 due to the knock- on effects of the Eurozone crisis, regulatory ambiguity in the United States, and the recent economic slowdown in Asia-Pacific countries, PEVC deal activity will soon pick up as the growing aging population, increasing purchasing power of the middle class, and rising consumerism drive the demand for first-rate healthcare. New analysis from Frost & Sullivan's Private Equity and Venture Capital Investments in Global Healthcare Industry reveals the volume of PEVC deals decreased from 2,721 in 2011 to 1,453 in 2013. The study covers the pharmaceutical, biotechnology, healthcare equipment, healthcare technology, healthcare providers, and life sciences sectors. For complimentary access to more information on this research, please visit: http://bit.ly/1fXUvuz. The average value of global PEVC deals in healthcare does not quite follow the same trend observed in the volume of PEVC deals between 2011 and 2013.

Informations

• Publié par: frost-sullivan
• Publié le: 08 avril 2014
• Nombre de lectures: 6
• Langue: English

Extrait

Frost & Sullivan: Patients Revive Healthcare Investments as Demand for High-quality Care Grows

PR Newswire

MOUNTAIN VIEW, California, April 8, 2014

-- PEVC deal activity intensifies in the US and Europe while transformations in business models and delivery advance

Though private equity and venture capital (PEVC) investments in the global healthcare industry have been on the decline since 2011 due to the knock-on effects of the Eurozone crisis, regulatory ambiguity in the United States, and the recent economic slowdown in Asia-Pacific countries, PEVC deal activity will soon pick up as the growing aging population, increasing purchasing power of the middle class, and rising consumerism drive the demand for first-rate healthcare.